Applying Nobel Prize-winning Yamanaka factor technology to induce partial cellular rejuvenation is opening revolutionary therapeutic frontiers in regenerative medicine. Detailed analysis within the Longevity Market report outlines how transient expression of OSKM reprogramming factors resets epigenetic age without causing cell identity loss or oncogenic transformation. Gene therapy vectors...